Imiquimod topical - Moberg Derma

Drug Profile

Imiquimod topical - Moberg Derma

Alternative Names: Imiquimod 0.09% - Moberg Derma; Limtop; Low-dose topical imiquimod - Moberg Derma; MOB-012

Latest Information Update: 13 Mar 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Moberg Derma
  • Class Adjuvants; Aminoquinolines; Antineoplastics; Antivirals; Small molecules
  • Mechanism of Action Interferon stimulants; Interleukin stimulants; Toll-like receptor 7 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Actinic keratosis; Basal cell cancer; Condylomata acuminata

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 11 Mar 2013 Discontinued - Phase-I for Basal cell cancer (in volunteers) in Germany (Topical)
  • 11 Mar 2013 Discontinued - Phase-I for Condylomata acuminata (in volunteers) in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top